Recombinant Human XIAP Protein，His

XIAP (X-linked inhibitor of apoptosis protein) is a member of the IAP (inhibitor of apoptosis protein) family, known for its critical role in regulating apoptosis and promoting cell survival. Research on XIAP has gained significant momentum due to its implications in various diseases, particularly cancer. Elevated levels of XIAP are often observed in several malignancies, where it contributes to the resistance of cancer cells to apoptosis, thus complicating treatment strategies. The understanding of XIAP's functional mechanisms has prompted extensive studies into its structure and interactions, highlighting its potential as a therapeutic target. Recombinant XIAP proteins serve as essential tools for these investigations, allowing scientists to explore the protein's specific interactions with other cellular components and its involvement in signaling pathways that govern cell fate. The development and characterization of recombinant XIAP proteins not only facilitate the deciphering of its biological functions but also pave the way for novel therapeutic approaches aimed at enhancing apoptosis in cancer cells, potentially overcoming drug resistance. As research progresses, elucidating the role of XIAP in both normal and pathological processes is expected to yield significant insights, contributing to the development of targeted therapies that can effectively combat cancers associated with XIAP dysregulation.